Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co LtdfiledCriticalYakult Honsha Co Ltd
Priority to JP6759481ApriorityCriticalpatent/JPS57185285A/ja
Priority to US06/336,494prioritypatent/US4399276A/en
Priority to CA000393558Aprioritypatent/CA1177487A/en
Priority to DE8282300104Tprioritypatent/DE3265308D1/de
Priority to EP82300104Aprioritypatent/EP0056692B1/en
Publication of JPS57185285ApublicationCriticalpatent/JPS57185285A/ja
Publication of JPS6247189B2publicationCriticalpatent/JPS6247189B2/ja
Rearrangements and cyclizations—XVI: Ring-opening reactions of 1, 1-diacetylcyclopropane with hydrazine and hydroxylamine derivatives as the novel synthesis of β-X-ethyl substituted pyrazoles and isoxazoles
Synthesis and biological evaluation of novel ri, r2 substituted 2-(4-((2-(4-alkoxyphenyl)-5-methyloxazol-4-yl) methyl)-1-alkyl-5-methyl-1h-pyrazol-3-yloxy)-6-(hydroxymethyl) tetrahydro-2h-pyran-3, 4, 5-triol having anti diabetic activity